Embedded Files
Kim EN, Lee HS, Trang NM, Hong JT, Jeong GS. In Silico Target Discovery of Kaempferol: Therapeutic Effect of Kaempferol on Atopic Dermatitis through Regulation of Aryl Hydrocarbon Receptor. Biomater Res. 2025;29:0270. Published 2025 Nov 11. doi:10.34133/bmr.0270
Trang NM, Kim EN, Jeong GS. Phloridzin Mitigates Gorham-Stout Disease by Dual Inhibition of Osteoclastogenesis Related to the Ca2+ Signaling Pathway and Vascular Proliferation. ACS Omega. 2025;10(33):37740-37760. Published 2025 Aug 18. doi:10.1021/acsomega.5c04384
Kim EN, Trang NM, Park CL, Kim SY, Na M, Jeong GS. Ameliorating Effect of Glehnia littoralis Extract on Periodontitis Through Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in an Experimental Periodontitis Model. Molecules. 2025;30(14):2903. Published 2025 Jul 9. doi:10.3390/molecules30142903
Lee HS, Kim EN, Jeong GS. Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure. PLoS One. 2025;20(3):e0314054. Published 2025 Mar 20. doi:10.1371/journal.pone.0314054
Pham TH, Trang NM, Kim EN, Jeong HG, Jeong GS. Citropten Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via the TRPV1 Receptor. ACS Omega. 2024;9(27):29829-29839. Published 2024 Jun 25. doi:10.1021/acsomega.4c03539
Kim TY, Kim EN, Jeong GS. Therapeutic Effects of Hinokitiol through Regulating the SIRT1/NOX4 against Ligature-Induced Experimental Periodontitis. Antioxidants (Basel). 2024;13(5):550. Published 2024 Apr 30. doi:10.3390/antiox13050550
Lee WJ, Kim EN, Trang NM, et al. Ameliorative Effect of Ginsenoside Rg6 in Periodontal Tissue Inflammation and Recovering Damaged Alveolar Bone. Molecules. 2023;29(1):46. Published 2023 Dec 20. doi:10.3390/molecules29010046
Pham TH, Kim EN, Trang NM, Jeong GS. Gallic acid induces osteoblast differentiation and alleviates inflammatory response through GPR35/GSK3β/β-catenin signaling pathway in human periodontal ligament cells. J Periodontal Res. 2024;59(1):204-219. doi:10.1111/jre.13208
Kim EN, Seo JA, Kim BH, Jeong GS. Defining the reactivity of nanoparticles to peptides through direct peptide reactivity assay (DPRA) using a high pressure liquid chromatography system with a diode array detector. Toxicol Res. 2023;39(3):485-495. Published 2023 May 16. doi:10.1007/s43188-022-00166-w
Trang NM, Kim EN, Pham TH, Jeong GS. Citropten Ameliorates Osteoclastogenesis Related to MAPK and PLCγ/Ca2+ Signaling Pathways through the Regulation of Amyloid Beta. J Agric Food Chem. 2023;71(26):10037-10049. doi:10.1021/acs.jafc.3c00368
Kim EN, Trang NM, Kang H, Kim KH, Jeong GS. Phytol Suppresses Osteoclast Differentiation and Oxidative Stress through Nrf2/HO-1 Regulation in RANKL-Induced RAW264.7 Cells. Cells. 2022;11(22):3596. Published 2022 Nov 14. doi:10.3390/cells11223596
Kim EN, Jeong GS. Inhibitory Effect of Periodontitis through C/EBP and 11β-Hydroxysteroid Dehydrogenase Type 1 Regulation of Betulin Isolated from the Bark of Betula platyphylla. Pharmaceutics. 2022;14(9):1868. Published 2022 Sep 5. doi:10.3390/pharmaceutics14091868
Lee HS, Kim EN, Jeong GS. Oral administration of Helianthus annuus leaf extract ameliorates atopic dermatitis by modulation of T cell activity in vivo. Phytomedicine. 2022;106:154443. doi:10.1016/j.phymed.2022.154443
Lee HS, Jeong GS. Protective Effects of 6,7,4'-Trihydroxyflavanone on Hypoxia-Induced Neurotoxicity by Enhancement of HO-1 through Nrf2 Signaling Pathway. Antioxidants (Basel). 2021;10(3):341. Published 2021 Feb 24. doi:10.3390/antiox10030341
Lee HS, Jeong GS. Therapeutic effect of kaempferol on atopic dermatitis by attenuation of T cell activity via interaction with multidrug resistance-associated protein 1. Br J Pharmacol. 2021;178(8):1772-1788. doi:10.1111/bph.15396
Lee HS, Jeong GS. 6,7,4′-Trihydroxyflavanone Prevents Methamphetamine-Induced T Cell Deactivation by Protecting the Activated T Cells from Apoptosis. Am J Chin Med. 2021;49(1):95-111. doi:10.1142/S0192415X21500051
Kim EN, Kim TY, Park EK, Kim JY, Jeong GS. Panax ginseng Fruit Has Anti-Inflammatory Effect and Induces Osteogenic Differentiation by Regulating Nrf2/HO-1 Signaling Pathway in In Vitro and In Vivo Models of Periodontitis. Antioxidants (Basel). 2020;9(12):1221. Published 2020 Dec 3. doi:10.3390/antiox9121221
Kim EN, Lee HS, Jeong GS. Cudratricusxanthone O Inhibits H2O2-Induced Cell Damage by Activating Nrf2/HO-1 Pathway in Human Chondrocytes. Antioxidants (Basel). 2020;9(9):788. Published 2020 Aug 25. doi:10.3390/antiox9090788
Lim JS, Kim JY, Lee S, et al. Bakuchicin attenuates atopic skin inflammation. Biomed Pharmacother. 2020;129:110466. doi:10.1016/j.biopha.2020.110466
1. 뷰테인을 유효성분으로 포함하는 치수질환 치료 또는 개선용 조성물
1. 뷰테인을 유효성분으로 포함하는 치수질환 치료 또는 개선용 조성물
(COMPOSITON CONTAINING BUTEIN FOR TREATMENT OR IMPROVEMENT OF DENTAL DISEASES)
No. 10-1263298 (May, 06, 2013)
2. 쿠드라트리구스잔톤 A를 유효성분으로 함유하는 유방암 예방 또는 치료용 약학조성물
2. 쿠드라트리구스잔톤 A를 유효성분으로 함유하는 유방암 예방 또는 치료용 약학조성물
(PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BREAST CANCER COMPRISING CUDRATRICUSXANTHONE A)
No. 10-1731214 (Apr, 21, 2017)
3. 쿠드라트리쿠스산톤 A를 포함하는 골다공증 예방 또는 치료용 조성물
3. 쿠드라트리쿠스산톤 A를 포함하는 골다공증 예방 또는 치료용 조성물
(COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS COMPRISING CUDRATRICUSXANTHONE A)
No. 10-2017-0116402 (Oct, 19, 2017)
4. 진피 분획물을 유효성분으로 포함하는 구강내 염증 억제용 조성물
4. 진피 분획물을 유효성분으로 포함하는 구강내 염증 억제용 조성물
(COMPOSITION FOR INHIBITING ORAL INFLAMMATION COMPRISING FRACTIONS CITRUS UNSHIU PEEL)
No. 10-2017-0126261 (Nov, 17, 2017)
5. 신장 보호 활성을 갖는 쿠드라트리쿠스잔톤 A를 유효성분으로 포함하는 신장 질환 예방 또는 치료용 조성물
5. 신장 보호 활성을 갖는 쿠드라트리쿠스잔톤 A를 유효성분으로 포함하는 신장 질환 예방 또는 치료용 조성물
(COMPOSITION FOR PREVENTING OR TREATING RENAL DISEASE COMPRISING CUDRATRICUSXANTHON A HAVING RENAL-PROTECTING ACTIVITY)
No. 10-1928656 (Dec, 06, 2018)
6. 꽃송이버섯 추출물을 유효성분으로 함유하는 골관절염 예방 또는 치료용 약학조성물
6. 꽃송이버섯 추출물을 유효성분으로 함유하는 골관절염 예방 또는 치료용 약학조성물
(PHARMACEUTICAL COMPOSITION FOR PREVENTINR OR TREATING OSTEOARTHRITIS COMPRISING SPARASSIS CRISPA)
No. 10-2019-0033506 (Mar, 29, 2019)
7. 털이슬 추출물을 함유하는 여성 폐경기 증후군 예방 또는 치료용 조성물
7. 털이슬 추출물을 함유하는 여성 폐경기 증후군 예방 또는 치료용 조성물
(COMPOSITION COMTAINING THE EXTRACTS OR FRACTIONS OF CIRCAEA MOLLIS SLEBOLD AND ZUCC FOR THE PREVENTION AND TREATMENT OF POSTMENOOAUSAL SYNDROME)
No. 10-2019-0135328 (Dec, 06, 2019)
8. 고미신 M2를 유효성분으로 포함하는 알레르기 질환 예방 또는 치료용 약학적 조성물
8. 고미신 M2를 유효성분으로 포함하는 알레르기 질환 예방 또는 치료용 약학적 조성물
(PHARMACEUTICAL COMPOSITION COMPRISING GOMISIN M2 FOR PREVENTING OR TREATING ALLERGIC DISEASE)
No. 10-2020-0121635 (Oct, 26, 2019)
9. 크리소파놀을 유효성분으로 포함하는 T 세포의 과활성 억제용 조성물, 및 이의 용도
9. 크리소파놀을 유효성분으로 포함하는 T 세포의 과활성 억제용 조성물, 및 이의 용도
(COMPOSITIONS FOR INHIBITING OVERACTIVITY OF T CELLS COMPRISING CHRYSOPHANOL AS AN ACTIVE INGREDIENT, AND USES THEREOF)
No. 10-2022-0102806 (Jul, 21, 2022)
10. 털머위 줄기 추출물을 유효성분으로 함유하는 알레르기 질환 예방 또는 치료용 조성물
10. 털머위 줄기 추출물을 유효성분으로 함유하는 알레르기 질환 예방 또는 치료용 조성물
(COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASE COMPRISING EXTRACT FROM THE STEM OF FARFUGIUM JAPONICUM (L.) KITAM.)
No. 10-2023-0025055 (Feb, 21, 2023)
11. 쇠뜨기 잎 추출물을 유효성분으로 함유하는 알레르기 질환 예방 또는 치료용 조성물
11. 쇠뜨기 잎 추출물을 유효성분으로 함유하는 알레르기 질환 예방 또는 치료용 조성물
(COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASE COMPRISING EXTRACT FROM THE LEAF OF EQUISETUM ARVENSE L.)
No. 10-2023-0025054 (Feb, 21, 2023)
12. 닭의장풀 추출물을 유효성분으로 함유하는 알레르기 질환 예방 또는 치료용 조성물
12. 닭의장풀 추출물을 유효성분으로 함유하는 알레르기 질환 예방 또는 치료용 조성물
(COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASE COMPRISING EXTRACT OF COMMELINA COMMUNIS L.)
No. 10-2023-0025053 (Feb, 21, 2023)
Page updated
Google Sites
Report abuse